Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Minocycline and Verapamil Reduce Riluzole's Effectiveness in a Preclinical Model System of Mechanisms of Sporadic Amyotrophic Lateral Sclerosis (ALS) Pathogenesis
Anterior Horn
(-)
160
Authors/Disclosures
Richelle A. Hemendinger, PhD (Carolinas Medical Center) No disclosure on file
No disclosure on file
No disclosure on file
Benjamin R. Brooks, MD, FÂé¶¹´«Ã½Ó³»­ (Clinical Trials Planning LLC) Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with Âé¶¹´«Ã½Ó³»­ that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Valerie Rundle-Gonzalez, MD (Medical Injury Rehabilitation Specialists) No disclosure on file